Canaccord Genuity Group Reaffirms “Buy” Rating for Phreesia (NYSE:PHR)

Phreesia (NYSE:PHR)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity Group in a report issued on Thursday, Benzinga reports. They presently have a $16.00 price objective on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 34.68% from the company’s current price.

Several other brokerages have also recently issued reports on PHR. Needham & Company LLC reaffirmed a “buy” rating and set a $14.00 price objective on shares of Phreesia in a research note on Monday. DA Davidson reissued a “buy” rating and issued a $14.00 target price on shares of Phreesia in a research note on Thursday, May 28th. Truist Financial boosted their target price on Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a report on Thursday, May 28th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a report on Friday, May 29th. Finally, Barclays reiterated an “equal weight” rating and set a $10.00 price objective (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Nine analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $16.71.

Phreesia Trading Up 0.3%

PHR stock opened at $11.88 on Thursday. Phreesia has a 12-month low of $7.77 and a 12-month high of $31.83. The business’s 50-day moving average is $11.19 and its 200 day moving average is $10.48. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The stock has a market cap of $734.30 million, a price-to-earnings ratio of 79.20 and a beta of 0.86.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The firm had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period in the prior year, the company posted $0.01 earnings per share. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Phreesia will post 0.39 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its position in Phreesia by 1,119.8% in the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after acquiring an additional 3,001 shares in the last quarter. Van ECK Associates Corp grew its holdings in Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares in the last quarter. New York State Teachers Retirement System purchased a new stake in shares of Phreesia in the 1st quarter valued at approximately $44,000. Rockefeller Capital Management L.P. lifted its holdings in Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after buying an additional 2,149 shares during the last quarter. Finally, Allworth Financial LP acquired a new position in shares of Phreesia in the 2nd quarter valued at $58,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia News Summary

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with Wall Street expectations, reducing the risk of a near-term outlook cut. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Phreesia reported positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, supporting balance-sheet improvement and potentially lowering future interest costs. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management identified AccessOne as a multi-year growth opportunity, giving investors an additional potential driver beyond the company’s core revenue expansion. Needham & Company also initiated or reiterated a Buy rating, adding analyst support. Needham Buy Rating
• Neutral Sentiment: The quarter’s revenue growth and profitability expansion were described as in line with expectations, suggesting execution remains steady but did not produce a major upside surprise. Phreesia Q2 2027 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were materially below consensus at $0.03 per share versus the expected $0.09-$0.11. The miss may limit upside for PHR despite the revenue beat and maintained full-year outlook. Phreesia Q2 Earnings and Revenues Lag Estimates

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.